AcouSort AB (publ)

Stockholm Stock Exchange ACOU.ST

AcouSort AB (publ) Return on Equity (ROE) for the year ending December 31, 2023

AcouSort AB (publ) Return on Equity (ROE) is NA for the year ending December 31, 2023. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

AcouSort AB (publ) Return on Equity (ROE) for the year ending December 31, 2022 was -65.68%.
AcouSort AB (publ) Return on Equity (ROE) for the year ending December 31, 2019 was -163.51%.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Stockholm Stock Exchange: ACOU.ST

AcouSort AB (publ)

CEO	Mr. Torsten Freltoft
IPO Date	Dec. 14, 2020
Location	Sweden
Headquarters	Building 406
Employees	17
Sector	Healthcare
Industries Biotechnology 3D Printing Cleaning Supplies Medical Instruments Metals Personal Care Pollution Treatment Silver

Description

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.

Key trends

Past 5 years